02.01.2013 Views

Download the presentation here: PDF

Download the presentation here: PDF

Download the presentation here: PDF

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Leaving Plenty of Unmet Need to Be Addressed<br />

19<br />

Relistor (Progenics/Wyeth);<br />

Tapentadol Constipation, (J&J), sedation, DOR<br />

agonists confusion, (Adolor/Pfizer);<br />

respiratory<br />

abuse-deterrent depression, mental opioids clouding,<br />

(King/Alpharma/Acura,<br />

renal colic, tolerance to<br />

prolonged use and risk of<br />

Pain Therapeutics, Acurox)<br />

abuse, misuse, addiction.<br />

Gastrointestinal ulcers,<br />

stomach bleeding,<br />

Celebrex tinnitus (Pfizer)<br />

PN400<br />

(Nexium/naproxen),<br />

AstraZeneca/Pozen<br />

Naproxcinod (NicOx)<br />

Gastric erosion, peptic ulcer,<br />

Topical NSAIDs<br />

inflammation of <strong>the</strong> duodenum and<br />

of <strong>the</strong> colon, renal toxicity with<br />

prolonged use<br />

Step 1: Mild Pain (1-3/10)<br />

• Aspirin (ASA)<br />

• Acetaminophen (APAP)<br />

• Nonsteroidal<br />

anti-inflammatory drugs (NSAIDs)<br />

• +/- Adjuvants<br />

World Health Organization<br />

© Defined Health, 2009<br />

Pain Insight Briefing<br />

Step 2: Moderate Pain (4-6/10)<br />

• APAP or ASA +<br />

– Codeine<br />

– Hydrocodone<br />

– Oxycodone<br />

– Dihydrocodeine<br />

– Tramadol (not available<br />

with APAP or ASA)<br />

– +/- Adjuvants<br />

Step 3: Severe Pain (7-10/10)<br />

• Morphine<br />

• Hydromorphone<br />

• Methadone<br />

• Levorphanol<br />

• Fentanyl<br />

• Oxycodone<br />

• +- Nonopiod analgesics<br />

• +/-Adjuvants<br />

•Adjuvant Therapy:<br />

– Anticonvulsants<br />

– Antidepressants<br />

– Corticosteroids<br />

– Dermal analgesics<br />

– Muscle relaxants<br />

– Stimulants

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!